lncRNA-HEIH在肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2021.01.018

摘要/Abstract

摘要： 长链非编码RNA(Long non-coding RNA,lncRNA)是一类新的非编码RNA,参与多种疾病的生物学进程。lncRNA-HEIH(High expression in hepatocellular carcinoma,HEIH)通过不同机制调节肿瘤增殖、迁移、侵袭、凋亡以及耐药,其表达水平与肿瘤的临床病理特征相关,在肿瘤发生发展中起关键作用。本文简要介绍了lncRNA-HEIH的概念,对其在肝细胞肝癌、肺癌、乳腺癌、结直肠癌、子宫内膜癌等多种恶性肿瘤中的生物学功能和分子机制进行了系统的综述,探讨了lncRNA-HEIH成为潜在的生物标记物和新的肿瘤治疗靶点的前景。

关键词: lncRNA, lncRNA-HEIH, 肿瘤, 生物标志物

Abstract: Long non-coding RNAs(lncRNA)are a new class of non-coding RNAs that participate in the biological processes of many diseases.lncRNA-HEIH(High expression in hepatocellular carcinoma,HEIH)regulates tumor proliferation,migration,invasion,apoptosis and drug resistance through different mechanisms.Its expression level is related to the clinicopathological characteristics of tumors and plays a key role in tumor occurrence and development.This article briefly introduces the concept of lncRNA-HEIH,and systematically reviews its biological functions and molecular mechanisms in hepatocellular carcinoma,lung cancer,breast cancer,colorectal cancer,endometrial cancer and other malignant tumors.The prospect of lncRNA-HEIH is considered as a potential biomarker and a new target for cancer treatment.

Key words: lncRNA, lncRNA-HEIH, Tumor, Biomarker

中图分类号:

R730.2

冯羽昕(综述),朱春荣(审校). lncRNA-HEIH在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2021, 35(1): 87-90.

FENG Yuxin,ZHU Chunrong. Research progress of lncRNA-HEIH in tumor[J]. Journal of Practical Oncology, 2021, 35(1): 87-90.

参考文献

1 Peng WX,Koirala P,Mo YY.lncRNA-mediated regulation of cell signaling in cancer[J].Oncogene,2017,36(41):5661-5667.
2 Akhade VS,Pal D,Kanduri C.Long noncoding RNA:genome organization and mechanism of action[J].Adv Exp Med Biol,2017,1008:47-74.
3 Fang Y,Fullwood MJ.Roles,functions,and mechanisms of long non-coding RNAs in cancer[J].Genomics Proteomics Bioinformatics,2016,14(1):42-54.
4 李思维.长链非编码RNA(lncRNA)在癌症中的作用[J].实用肿瘤学杂志,2019,33(5):471-475.
5 Yang F,Zhang L,Huo XS,et al.Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans[J].Hepatology,2011,54(5):1679-1689.
6 Wang J,Su Z,Lu S,et al.lncRNA HOXA-AS2 and its molecular mechanisms in human cancer[J].Clin Chim Acta,2018,485:229-233.
7 Zhao CY,Fei XQ,Xu BK.Long non-coding RNA HEIH contributes to diabetic retinopathy by regulating miR-939/VEGF axis[J].Int J Clin Exp Pathol,2019,12(6):2022-2033.
8 Forner A,Llovet JM,Bruix J.Hepatocellular carcinoma[J].The Lancet,2012,379(9822):1245-1255.
9 Wong C,Tsang F,Ng I.Non-coding RNAs in hepatocellular carcinoma:molecular functions and pathological implications[J].Nat Rev Gastroenterol Hepatol,2018,15(3):137-151.
10 杨哲锋,李娟,马志元,等.血浆lncRNA-HEIH表达水平与肝癌发病风险的关联分析[J].现代肿瘤医学,2015,23(1):80-84.
11 Zhang YQ,Li ZY,Zhong QT.Molecular mechanism of HEIH and HULC in the proliferation and invasion of hepatoma cells[J].Int J Clin Exp Med,2015,8(8):12956-12962.
12 Zhang C,Yang X,Qi Q,et al.lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma[J].Cancer Biomark,2018,21(3):651-659.
13 Ruan LJ,Huang LF,Zhao LL,et al.The interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in hepatitis B patients[J].Gastroenterol Res Pract,2018,2018:9187316.
14 胡建兰,黎利娟,易小猛,等.HBx上调lncRNA-HEIH对肝癌细胞增殖的影响[J].中华肝脏外科手术学电子杂志,2017,6(2):139-143.
15 Ma YB,Cao D,Li G,et al.Silence of lncRNA HEIH suppressed liver cancer cell growth and metastasis through miR-199a-3p/mTOR axis[J].J Cell Biochem,2019,120(10):17757-17766.
16 He Y,Meng XM,Huang C,et al.Long noncoding RNAs:novel insights into hepatocelluar carcinoma[J].Cancer Lett,2014,344(1):20-27.
17 Samaloty NM,Shabayek MI,Ghait RS,et al.Assessment of lncRNA GAS5,lncRNA HEIH,lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers:recent insights into Egyptian patients with hepatitis C virus type 4[J].World J Gastroenterol,2020,26(2):168-183.
18 马庆,吕宗军.lncRNA-HEIH和lncRNA-HULC与乙型肝炎相关性肝病的相关性[J].中国卫生检验杂志,2019,29(23):2863-2866.
19 Jia KG,Chen F,Xu L.Long noncoding RNA HEIH promotes the proliferation and metastasis of non-small cell lung cancer[J].J Cell Biochem,2019,120(3):3529-3538.
20 蒋庆锋,于永魁,程金华,等.lncRNA HEIH通过miR-98-5p调节肺癌细胞增殖和凋亡[J].基础医学与临床,2020,40(1):30-36.
21 Li P,Zhou B,Lv YT,et al.lncRNA HEIH regulates cell proliferation and apoptosis through miR-4458/SOCS1 axis in triple-negative breast cancer[J].Hum Cell,2019,32(4):522-528.
22 Zhao J,Meng R,Yao Q,et al.Long non-coding RNA HEIH promotes breast cancer development via negative modulation of microRNA-200b[J].Pharmazie,2019,74(8):471-476.
23 Cui CH,Zhai DY,Cai LX,et al.Long Noncoding RNA HEIH promotes colorectal cancer tumorigenesis via counteracting miR-939-mediated transcriptional repression of Bcl-xL[J].Cancer Res Treat,2018,50(3):992-1008.
24 Guo JL,Tang T,Li JH,et al.lncRNA HEIH enhances paclitaxel-tolerance of endometrial cancer cells via activation of MAPK signaling pathway[J].Pathol Oncol Res,2019,(8):1-10.
25 Zhao HY,Xing GP,Wang YY,et al.Long noncoding RNA HEIH promotes melanoma cell proliferation,migration and invasion via inhibition of miR-200b/a/429[J].Biosci Rep,2017,37(3):20170682.
26 Wang DW,You D,Pan YH,et al.Downregulation of lncRNA-HEIH curbs esophageal squamous cell carcinoma progression by modulating miR-4458/PBX3[J].Thorac Cancer,2020,11(7):1963-1971.
27 Wan T,Wang H,Gou M,et al.lncRNA HEIH promotes cell proliferation,migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4[J].Biomed Pharmacother,2020,125:109916.
28 Gao C,Zhao D,Zhao Q,et al.Microarray profiling and co-expression network analysis of lncRNAs and mRNAs in ovarian cancer[J].Cell Death Discov,2019,5:93.
29 邵志伟,刁建华,黄其根,等.长链非编码RNA HEIH在胃癌患者的表达及临床意义[J].江苏医药,2019,45(8):794-796.

[1]	任思颖,秦明芳,陈杨,石青萍,成会荣,高娇,文洪梅. 云南省肿瘤登记地区2011—2015年宫颈癌发病和死亡特征及时间趋势[J]. 实用肿瘤学杂志, 2021, 35(1): 13-17.
[2]	刘学静(综述),徐燕颖(审校). B7-H6在恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2021, 35(1): 46-49.
[3]	郑志远,综述,曲国蕃(审校). 长链非编码RNA SNHG3在恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2021, 35(1): 50-54.
[4]	张文文,姜亮亮(综述),王晶(审校). CAR-T疗法在卵巢癌中的应用前景[J]. 实用肿瘤学杂志, 2021, 35(1): 59-63.
[5]	杨思琦,宋启斌,李清清(综述),姚颐(审校). 靶向抑制FGFRs信号在治疗恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2021, 35(1): 73-77.
[6]	王庆亮,赵艳峰,蒋燕(综述),姜格宁(审校). TPX2与肿瘤关系的研究进展[J]. 实用肿瘤学杂志, 2021, 35(1): 83-86.
[7]	文洪梅, 陈杨, 石青萍, 任思颖, 高娇, 秦明芳. 2016年云南省肿瘤登记地区恶性肿瘤的发病和死亡分析[J]. 实用肿瘤学杂志, 2020, 34(6): 485-490.
[8]	相智声, 马晶昱, 钟文玲, 陈铁晖, 林永添, 江惠娟, 周衍. 福建省2016年恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2020, 34(6): 491-494.
[9]	孙晓凯, 刘付东, 梁季, 郑春早, 周金意. 江苏省盐城市2008—2018年消化道肿瘤死亡情况及其变化趋势分析[J]. 实用肿瘤学杂志, 2020, 34(6): 495-499.
[10]	李建昕, 沈彬杰, 王璇. 恶性肿瘤社区随访模式的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 540-543.
[11]	陈敏, 刘莉萍, 张玲. iTRAQ技术在消化道肿瘤研究中的应用进展[J]. 实用肿瘤学杂志, 2020, 34(6): 549-553.
[12]	左蕊, 金路, 刘丽, 刘小嘉, 赵鹏宇, 向小燕. miR-409-3p在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 554-559.
[13]	李荣迪, 李学东. 非编码RNA在膀胱癌中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 565-570.
[14]	宋家羽, 冯越, 王棹, 张云艳. 外泌体与妇科恶性肿瘤相关性的最新研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 571-575.
[15]	刘恒昌, 魏然, 李春香, 刘正, 陈海鹏, 关旭, 赵志勋, 邹霜梅, 王锡山, 姜争. NOX4在结肠癌组织中的表达及与预后的关系[J]. 实用肿瘤学杂志, 2020, 34(5): 391-397.